dc.creator | Leontiadou, Hari | |
dc.creator | Galdadas, Ioannis | |
dc.creator | Cournia, Zoe | |
dc.date | 2017-04-27 | |
dc.date.accessioned | 2017-05-06T13:20:57Z | |
dc.date.available | 2017-05-06T13:20:57Z | |
dc.identifier.uri | http://hdl.handle.net/21.15102/VISEEM-254 | |
dc.description | This dataset contains Molecular Dynamics simulations
trajectories of the full length Wild-Type (normal) PI3Ka. These
simulations are provided in two independent replicate trajectories (Run
1 and Replicate 1) | |
dc.description.abstract | The kinase PI3Ka is involved in fundamental cellular
processes such as cell proliferation and differentiation and is
frequently mutated in human malignancies. One of the most common
mutations is E545K, which results in an amino acid change of opposite
charge. It has been recently proposed that in this oncogenic
charge-reversal mutation, the interactions between the protein
catalytic and regulatory subunits are abrogated, resulting in loss of
regulation and constitutive PI3Ka activity, which can lead to
oncogenesis. To assess the mechanism of protein overactivation,
extensive MD simulations were performed to examine conformational
changes differing among wild type (WT) and mutant proteins as they
occur in the microsecond timescale. In the mutant protein form, we
observe a spontaneous detachment of the nSH2 PI3Ka domain (regulatory
subunit, p85a) from the helical domain (catalytic subunit, p110a),
which results in significant loss of communication between the
regulatory and catalytic subunits. We examine the allosteric network of
the two proteins and show that a cluster of residues around the
mutation is key in delivering communication signals between the
catalytic and regulatory subunits. Our results demonstrate the
dynamical and structural differences of the two proteins in atomic
detail and indicate a possible mechanism for the enzyme
overactivation. | |
dc.description.sponsorship | VI-SEEM | |
dc.publisher | BRFAA | |
dc.subject | cancer, PI3Ka, PI3K alpha, Molecular Dynamics simulations, mutation, E545K, oncogene, breast cancer | |
dc.title | Insights into the mechanism of the PIK3CA E545K activating mutation using MD simulations | |
dc.rights.license | Free upon contacting the authors | |